These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 26519465

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Deoxyribonucleoside treatment rescues EtBr-induced mtDNA depletion in iPSC-derived neural stem cells with POLG mutations.
    Kristiansen CK, Furriol J, Chen A, Sullivan GJ, Bindoff LA, Liang KX.
    FASEB J; 2023 Sep; 37(9):e23139. PubMed ID: 37584631
    [Abstract] [Full Text] [Related]

  • 3. Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatment.
    Brañas Casas R, Zuppardo A, Risato G, Dinarello A, Celeghin R, Fontana C, Grelloni E, Gilea AI, Viscomi C, Rasola A, Dalla Valle L, Lodi T, Baruffini E, Facchinello N, Argenton F, Tiso N.
    Cell Death Dis; 2024 Apr 20; 15(4):281. PubMed ID: 38643274
    [Abstract] [Full Text] [Related]

  • 4. Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseases.
    Pitayu L, Baruffini E, Rodier C, Rötig A, Lodi T, Delahodde A.
    Hum Mol Genet; 2016 Feb 15; 25(4):715-27. PubMed ID: 26692522
    [Abstract] [Full Text] [Related]

  • 5. In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells.
    Spelbrink JN, Toivonen JM, Hakkaart GA, Kurkela JM, Cooper HM, Lehtinen SK, Lecrenier N, Back JW, Speijer D, Foury F, Jacobs HT.
    J Biol Chem; 2000 Aug 11; 275(32):24818-28. PubMed ID: 10827171
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patients.
    Long X, Wang X, Chen Y, Guo X, Zhou F, Fan Y, Ge N, Guo M, Zhang Z, Dong G.
    Bull Cancer; 2017 Jun 11; 104(6):500-507. PubMed ID: 28457473
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Absence of both MGME1 and POLG EXO abolishes mtDNA whereas absence of either creates unique mtDNA duplications.
    Gonzalez CD, Nissanka N, Van Booven D, Griswold AJ, Moraes CT.
    J Biol Chem; 2024 Apr 11; 300(4):107128. PubMed ID: 38432635
    [Abstract] [Full Text] [Related]

  • 12. POLG mutations cause decreased mitochondrial DNA repopulation rates following induced depletion in human fibroblasts.
    Stewart JD, Schoeler S, Sitarz KS, Horvath R, Hallmann K, Pyle A, Yu-Wai-Man P, Taylor RW, Samuels DC, Kunz WS, Chinnery PF.
    Biochim Biophys Acta; 2011 Mar 11; 1812(3):321-5. PubMed ID: 21138766
    [Abstract] [Full Text] [Related]

  • 13. Heterozygous p.Y955C mutation in DNA polymerase γ leads to alterations in bioenergetics, complex I subunit expression, and mtDNA replication.
    Rahman MM, Young CKJ, Goffart S, Pohjoismäki JLO, Young MJ.
    J Biol Chem; 2022 Aug 11; 298(8):102196. PubMed ID: 35760101
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase gamma.
    Lewis W, Day BJ, Kohler JJ, Hosseini SH, Chan SS, Green EC, Haase CP, Keebaugh ES, Long R, Ludaway T, Russ R, Steltzer J, Tioleco N, Santoianni R, Copeland WC.
    Lab Invest; 2007 Apr 11; 87(4):326-35. PubMed ID: 17310215
    [Abstract] [Full Text] [Related]

  • 17. No correlation between mtDNA amount and methylation levels at the CpG island of POLG exon 2 in wild-type and mutant human differentiated cells.
    Steffann J, Pouliet A, Adjal H, Bole C, Fourrage C, Martinovic J, Rolland-Galmiche L, Rotig A, Tores F, Munnich A, Bonnefont JP.
    J Med Genet; 2017 May 11; 54(5):324-329. PubMed ID: 28069933
    [Abstract] [Full Text] [Related]

  • 18. Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion.
    Taanman JW, Rahman S, Pagnamenta AT, Morris AA, Bitner-Glindzicz M, Wolf NI, Leonard JV, Clayton PT, Schapira AH.
    Hum Mutat; 2009 Feb 11; 30(2):248-54. PubMed ID: 18828154
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial DNA polymerase-gamma and human disease.
    Hudson G, Chinnery PF.
    Hum Mol Genet; 2006 Oct 15; 15 Spec No 2():R244-52. PubMed ID: 16987890
    [Abstract] [Full Text] [Related]

  • 20. [Mitochondrial DNA depletion and POLG mutations in a patient with sensory ataxia, dysarthria and ophthalmoplegia].
    Posada IJ, Gallardo ME, Domínguez C, Rivera H, Cabello A, Arenas J, Martín MA, Garesse R, Bornstein B.
    Med Clin (Barc); 2010 Oct 02; 135(10):452-5. PubMed ID: 20576279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.